Researchers test which skin cancer grading system best predicts risk

NCT ID NCT05695222

Recruiting now Knowledge-focused Sponsor: Queen Mary University of London Source: ClinicalTrials.gov ↗

Summary

This study aims to find out which existing grading system best predicts which patients with a common skin cancer (cutaneous squamous cell carcinoma) are at higher risk of the cancer coming back or spreading. Researchers will look at the medical records of 1,500 patients from two UK clinics to see how well current staging methods match actual patient outcomes. The goal is to help doctors better identify patients who need closer monitoring.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Dr Emilia Peleva
ACTIVE_NOT_RECRUITING

London, United Kingdom
Whipps Cross University Hospital
RECRUITING

London, E11 1NR, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CUTANEOUS SQUAMOUS CELL CARCINOMA